Antimicrobial Drug Development: Few Incentives, Many Task Force Meetings
This article was originally published in The Pink Sheet Daily
Executive Summary
The Transatlantic Taskforce on Antimicrobial Resistance's latest report suggests limited progress, but a lack of financial incentives in Europe means companies aren’t innovating in the area.